# Solid Biosciences (SLDB) — News

SLDB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sldb/news

## Recent headlines

- [Payward-Saldo deal seen closing in 2027](https://www.ainvest.com/news/payward-saldo-deal-closing-2027-2610) — AInvest Wire, Oct 14, 2026
  The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
- [Solitron Devices, Inc. announces fiscal 2027 second quarter results](https://www.ainvest.com/news/solitron-devices-announces-fiscal-2027-quarter-results-2610) — AInvest Wire, Oct 13, 2026
  Solitron Devices, Inc. (SODI) has released its fiscal 2027 second-quarter results, marking a period of strategic development for the company. While specific financial figures were not disclosed in the available materials, the firm announced a strategic review process amid record levels of…
- [Solid Biosciences Inc: RBC initiates coverage with outperform rating; price target $18](https://www.ainvest.com/news/solid-biosciences-rbc-initiates-coverage-outperform-rating-price-target-18-2609) — AInvest Wire, Sep 16, 2026
  RBC Capital Markets has initiated coverage on Solid Biosciences Inc. (NASDAQ: SLDB) with an "Outperform" rating and a price target of $18, reflecting the firm's confidence in the company's clinical progress and strategic direction. Solid Biosciences, a biotechnology firm focused on developing gene…
- [Solid Biosciences Inc files for offering of up to $200 mln in common stock - SEC filing](https://www.ainvest.com/news/solid-biosciences-files-offering-200-mln-common-stock-sec-filing-2608) — AInvest Wire, Aug 6, 2026
  Solid Biosciences Inc. (Nasdaq: SLDB) has announced the pricing of an underwritten offering of 35,739,810 shares of its common stock at an offering price of $4.03 per share, with an aggregate gross offering value of approximately $200.0 million before underwriting discounts and other expenses. In…
- [Solid Biosciences files mixed securities shelf](https://www.ainvest.com/news/solid-biosciences-files-mixed-securities-shelf-2608) — AInvest Wire, Aug 6, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).